Product image of Medaxone (Ceftriaxone) supplied by GNH India

Medaxone

Active Ingredient:
Ceftriaxone
Origin:
EU

Medaxone (Ceftriaxone)

Ceftriaxone, the active ingredient in Medaxone, is a cephalosporin presented as a sterile powder for injection for intramuscular and intravenous use. It is employed to treat a range of serious bacterial infections in both adult and pediatric patients.

GNH India supplies Medaxone as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Medochemie Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ceftriaxone is a broad‑spectrum cephalosporin used to manage bacterial infections affecting various organ systems.

  • Community‑acquired pneumonia: eliminates the causative pathogens and improves respiratory function.
  • Meningitis: penetrates the cerebrospinal fluid to eradicate meningococcal and pneumococcal organisms.
  • Gonorrhea: provides rapid bactericidal activity against Neisseria gonorrhoeae.
  • Urinary tract infection: treats complicated infections caused by susceptible Gram‑negative bacteria.
  • Skin and soft‑tissue infection: resolves cellulitis and wound infections caused by susceptible strains.

How It Works

  • Ceftriaxone binds to penicillin‑binding proteins on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis, resulting in a bactericidal effect against susceptible Gram‑positive and Gram‑negative organisms.

Side Effects

Ceftriaxone may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects

  • Injection site pain: local discomfort or erythema at the administration site.
  • Diarrhea: mild to moderate loose stools.
  • Nausea: occasional feeling of queasiness.
  • Rash: transient skin eruptions.
  • Elevated liver enzymes: mild, transient increase in hepatic transaminases.
  • Vaginal candidiasis: overgrowth of yeast causing discharge.

Serious or Rare Side Effects

  • Anaphylaxis: severe, life‑threatening allergic reaction.
  • Stevens‑Johnson syndrome: severe mucocutaneous blistering.
  • Hemolytic anemia: immune‑mediated destruction of red blood cells.
  • Pseudomembranous colitis: Clostridioides difficile infection causing severe colitis.
  • Renal impairment: acute kidney injury in susceptible patients.
  • Biliary sludge or gallstones: precipitation of calcium‑containing salts in the gallbladder.

Precautions & Warnings

Ceftriaxone requires careful consideration of patient‑specific factors and proper handling.

  • Renal or hepatic dysfunction: adjust therapy and monitor function closely.
  • Neonates (≤28 days) or infants (≤3 months) with hyperbilirubinemia: avoid due to risk of bilirubin displacement.
  • History of hypersensitivity to β‑lactams: assess risk before administration.
  • Concomitant calcium‑containing solutions in neonates: avoid mixing to prevent precipitation.
  • Prolonged therapy: monitor for secondary infections such as C. difficile.
  • Store below 25°C: keep in original container, protect from moisture and light.

Avoid Interactions

Ceftriaxone can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid)

  • Calcium‑containing IV solutions in neonates: risk of insoluble precipitate.
  • Warfarin: potentiates anticoagulant effect, increasing bleeding risk.
  • Aminoglycosides: may enhance nephrotoxicity when used together.

Moderate Interactions (Monitor Closely)

  • Oral contraceptives: possible reduction in contraceptive effectiveness.
  • Diuretics: may increase risk of electrolyte disturbances.
  • Antacids containing aluminum or magnesium: may affect absorption if given orally (not typical for injectable form).

Frequently Asked Questions

Medaxone contains ceftriaxone, a broad‑spectrum cephalosporin indicated for serious bacterial infections such as community‑acquired pneumonia, meningitis, gonorrhea, urinary tract infections, and skin or soft‑tissue infections caused by susceptible organisms.

Ceftriaxone binds to penicillin‑binding proteins on the bacterial cell wall, blocking the cross‑linking of peptidoglycan strands. This inhibition weakens the wall, causing osmotic rupture and bacterial cell death, providing a bactericidal effect against many Gram‑positive and Gram‑negative pathogens.

The specific dose of Medaxone is determined by the prescribing clinician based on the infection type, severity, patient age, weight, and renal or hepatic function. Dosage regimens are individualized and should follow the prescriber’s instructions.

The safety of ceftriaxone in pregnancy has not been definitively established, and it is classified as pregnancy category unknown. It should be used only if the potential benefit justifies the potential risk to the fetus. Limited data suggest minimal excretion in breast milk, but caution is advised.

To request Medaxone, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Compared with other third‑generation cephalosporins, ceftriaxone offers a long half‑life allowing once‑daily dosing, high tissue penetration, and a broad spectrum covering many Gram‑negative and some Gram‑positive organisms. Its convenience and spectrum often make it a preferred choice for severe infections requiring intravenous therapy.

Medaxone should be stored below 25 °C in its original packaging, protected from moisture and light. Reconstituted solutions must be used promptly and discarded according to local guidelines; they should not be frozen or exposed to excessive heat.

Medaxone is supplied as a sterile powder for injection and is reconstituted with a suitable diluent. It can be given intravenously or intramuscularly by a qualified healthcare professional, following aseptic technique and the prescriber’s dosing instructions.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, Stevens‑Johnson syndrome, hemolytic anemia, and biliary sludge or gallstone formation with prolonged use. Patients should be monitored for signs of these conditions and managed promptly if they occur.

Medaxone should be avoided in patients with a known hypersensitivity to ceftriaxone or other β‑lactam antibiotics. Neonates (≤28 days) receiving calcium‑containing solutions, and individuals with a history of severe allergic reactions to cephalosporins should not be treated with this product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ceftriaxone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT